g.varga
Submits third-party assay reports on material purchased directly. Based in Aarhus.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.57%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043250 | GHK-Cu | CPC | CPC-2601-D1258 | PeptideMeter | 2026-Q2 | 98.09 | 6.85 | 89.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042563 | Tirzepatide | HJ | HJ-2605-D6191 | Janoshik | 2026-Q2 | 98.42 | 4.60 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041276 | Semaglutide | WWB | WWB-2507-V2845 | Nordanalyt | 2025-Q4 | 99.36 | 4.63 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020226 | Tirzepatide | GGPeps | GGPE-2502-J1624 | Medutest | 2025-Q3 | 98.57 | 5.96 | 98.9 | Buyer-sourced | 0 | PASS |
| AX-2025-019775 | PEG-MGF | Homopeptide | HOMO-2412-B4014 | Janoshik | 2025-Q2 | 98.10 | 4.65 | 100.3 | Laboratory-retained | 0 | PASS |
| AX-2025-018423 | Semaglutide | WWB | WWB-2501-S2183 | PeptideMeter | 2025-Q1 | 98.99 | 4.02 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019954 | TB-500 | HJ | HJ-2501-A6454 | Janoshik | 2025-Q1 | 99.66 | 4.95 | 90.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020991 | CJC-1295 with DAC | WXT | WXT-2409-Y3760 | Janoshik | 2025-Q1 | 97.21 | 5.47 | 102.2 | Buyer-sourced | 1 | FAIL |
| AX-2024-004420 | Semax | GSP | GSP-2404-P2784 | Medutest | 2024-Q3 | 99.93 | 7.98 | 88.6 | Buyer-sourced | 1 | MARGINAL |